CAS 1314238-96-4

Duligotuzumab

CAS: 1314238-96-4

Duligotuzumab is a dual-targeting anti-EGFR/HER3 mAb that blocks signaling and induces ADCC for tumors with poor prognosis.

Reinheit: 97.7% (SDS-PAGE); 96.3% (SEC-HPLC) - ≥95% (SDS-PAGE); 95.19% (SEC-HPLC)

Farbe und Form: Liquid

Ref: TM-T9901A-828

Duligotuzumab

CAS: 1314238-96-4

bispecific humanized IgG1 monoclonal antibody to EGFR and HER3.

Ref: 3D-CLA1300

Duligotuzumab

CAS: 1314238-96-4

Duligotuzumab (MEHD-7945A) is a bispecific humanised IgG-κ monoclonal antibody targeting HER3 and EGFR, solid tumours, head and neck cancer,colorectal cancer.

Reinheit: 95%

Farbe und Form: Liquid

Ref: TM-T80604